Table 2.
The number of data sets (out of 42) for which the Wilcoxon test was significant (percentages in parentheses) indicating that non-CpG-creating mutations were observed at higher frequencies than, otherwise similar, CpG-creating mutations
| Summary of comparisons | ||
|---|---|---|
| Comparisons | AG | TC |
| Synonymous: CpG versus non-CpG | 32 (76.2%) | 28 (66.7%) |
| Non-synonymous: CpG versus non-CpG | 10 (23.8%) | 17 (40.5%) |
| Synonymous versus non-synonymous | 38 (90.5%) | 38 (90.5%) |